Dual-Energy CT Enterography in Intestinal Tuberculosis: Role of Relative Enhancement Calculated on Iodine Maps in Assessing Disease Activity

Abstract

Objective

This article studies the role of dual-energy computed tomography (DECT) enterography with iodine material decomposition images in activity assessment of tuberculosis of the bowel.

Materials and Methods

Twenty-four patients with suspected tuberculous bowel involvement were enrolled in this prospective study. All patients underwent DECT enterography as well as endoscopy and biopsy. Quantitative assessment of iodine overlay images was done to map the absolute and relative iodine uptake in involved segments of the bowel and lymph nodes. Comparison of the iodine uptake was made with histopathological activity grading using Spearman's correlation. The temporal change in the iodine uptake on posttreatment versus pretreatment group was recorded and tested for significance using Student's t-test and Wilcoxon signed rank test.

Results

Excellent correlation was found between grading of inflammatory activity on histopathology and relative bowel enhancement measured on iodine maps (Spearman's rho 0.895, p < 0.001). Attenuation values and absolute iodine uptake in the bowel showed no significant difference in the pre- and posttreatment groups (p > 0.05), while relative bowel as well as lymph nodal enhancement were significantly different (p = 0.001 and 0.008, respectively).

Conclusion

Uptake on the iodine maps in DECT data set showed correlation with histopathology as well as posttreatment resolution, suggesting the role of DECT in disease activity assessment.

Keywords

dual-energy CT - intestine - iodine maps - lymph nodes - tuberculosis

Ethical Approval

The Institutional Review Board of Post Graduate Institute of Medical Education and Research approved this prospective study and Ethical approval number is INT/IEC/2017/1178.

Patients' Consent

Written informed consent has been taken from all the patients.

Publication History

Article published online:
21 August 2025

• References

• 1 Sharma R, Madhusudhan KS, Ahuja V. Intestinal tuberculosis versus Crohn's disease: clinical and radiological recommendations. Indian J Radiol Imaging 2016; 26 (02) 161-172
• 2 Kalra N, Agrawal P, Mittal V. et al. Spectrum of imaging findings on MDCT enterography in patients with small bowel tuberculosis. Clin Radiol 2014; 69 (03) 315-322
• 3 De Backer AI, Mortelé KJ, De Keulenaer BL, Parizel PM. Tuberculosis: epidemiology, manifestations, and the value of medical imaging in diagnosis. JBR-BTR 2006; 89 (05) 243-250
• 4 Rasheed S, Zinicola R, Watson D, Bajwa A, McDonald PJ. Intra-abdominal and gastrointestinal tuberculosis. Colorectal Dis 2007; 9 (09) 773-783
• 5 Zhao XS, Wang ZT, Wu ZY. et al. Differentiation of Crohn's disease from intestinal tuberculosis by clinical and CT enterographic models. Inflamm Bowel Dis 2014; 20 (05) 916-925
• 6 Young BM, Fletcher JG, Booya F. et al. Head-to-head comparison of oral contrast agents for cross-sectional enterography: small bowel distention, timing, and side effects. J Comput Assist Tomogr 2008; 32 (01) 32-38
• 7 Lee SS, Kim AY, Yang SK. et al. Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques. Radiology 2009; 251 (03) 751-761
• 8 Krishna S, Kalra N, Singh P. et al. Small-bowel tuberculosis: a comparative study of MR enterography and small-bowel follow-through. AJR Am J Roentgenol 2016; 207 (03) 571-577
• 9 Kapoor VK, Chattopadhyaya TK, Sharma LK. Abdominal tuberculosis. Gut 1986; 27 (08) 990-991
• 10 Logan VS. Anorectal tuberculosis. Proc R Soc Med 1969; 62 (12) 1227-1230
• 11 Sharma V, Singh H, Mandavdhare HS. Defining ‘satisfactory response’ to therapy in abdominal tuberculosis: a work in progress. Infect Disord Drug Targets 2020; 20 (02) 111-114
• 12 Sharma V, Mandavdhare HS, Lamoria S, Singh H, Kumar A. Serial C-reactive protein measurements in patients treated for suspected abdominal tuberculosis. Dig Liver Dis 2018; 50 (06) 559-562
• 13 Patino M, Prochowski A, Agrawal MD. et al. Material separation using dual-energy CT: current and emerging applications. Radiographics 2016; 36 (04) 1087-1105
• 14 McCollough CH, Leng S, Yu L, Fletcher JG. Dual- and multi-energy CT: principles, technical approaches, and clinical applications. Radiology 2015; 276 (03) 637-653
• 15 Dane B, Sarkar S, Nazarian M. et al. Crohn disease active inflammation assessment with iodine density from dual-energy CT enterography: comparison with histopathologic analysis. Radiology 2021; 301 (01) 144-151
• 16 Ma L, Zhu Q, Li Y. et al. The potential role of CT enterography and gastrointestinal ultrasound in the evaluation of anti-tubercular therapy response of intestinal tuberculosis: a retrospective study. BMC Gastroenterol 2019; 19 (01) 106
• 17 Geng X. Spectral CT enterography in Crohn's disease: correlation of disease activity on spectral CT enterography with clinical parameters. 2014 https://dx.doi.org/10.1594/ecr2014/C-1094
• 18 Booya F, Fletcher JG, Huprich JE. et al. Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterography. Radiology 2006; 241 (03) 787-795
• 19 Bodily KD, Fletcher JG, Solem CA. et al. Crohn disease: mural attenuation and thickness at contrast-enhanced CT enterography–correlation with endoscopic and histologic findings of inflammation. Radiology 2006; 238 (02) 505-516
• 20 Xu X, Zhu J, Wang X, Zhu C, Wu X. Diagnostic performance of dual-energy CT in nonspecific terminal ileitis. Jpn J Radiol 2022; 40 (10) 1069-1078
• 21 Singh AK, Kumar R, Gupta P. et al. FDG-PET-CT enterography helps determine clinical significance of suspected ileocecal thickening: a prospective study. Dig Dis Sci 2021; 66 (05) 1620-1630